New study on cognitive archaeology and tactile responses to the lithic industry

The Paleoneurobiology group of the Centro Nacional de Investigación sobre la Evolución Humana (CENIEH), led by Emiliano Bruner, has just published, in collaboration with the Museo de la Evolución Humana (MEH) in Burgos and the company Sociograph from Valladolid, a new paper on cognitive archaeology in which the hand-tool relationship is studied, analyzing the geometry of the tools, the grasp […]

Continue reading »

Robust immune responses for herpes zoster subunit vaccine

(HealthDay)—Recipients of the herpes zoster subunit vaccine (HZ/su), consisting of varicella-zoster virus glycoprotein E (gE) and AS01B Adjuvant System, develop robust immune responses, according to a study published in the June 1 issue of The Journal of Infectious Diseases. Anthony L. Cunningham, M.D., from the University of Sydney, and colleagues presented immunogenicity results from two trials involving patients aged 50 […]

Continue reading »

First-in-human clinical trial of new targeted therapy drug reports promising responses for multiple

A phase I, first-in-human study led by The University of Texas MD Anderson Cancer Center reveals for the first time, an investigational drug that is effective and safe for patients with cancers caused by an alteration in the receptor tyrosine kinase known as RET. The drug appears to be promising as a potential therapy for RET-driven cancers, such as medullary […]

Continue reading »

Mathematical modeling offers new way to understand variable responses to targeted therapy

Cancer therapies that target a specific protein have improved outcomes for patients. However, many patients eventually develop resistance to these targeted therapies and their cancer comes back. It is believed that differences among tumor cells, or heterogeneity, may contribute to this drug resistance. Moffitt Cancer Center researchers are using a unique approach by combining typical cell culture studies with mathematical […]

Continue reading »